Diamond Biofund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
25
- Portfolio
-
11
- Exits
-
14
Diamond Biofund General Information
Company Description
Founded in 2013, Diamond Biofund is a venture capital firm based in Taipei, Taiwan. The firm seeks to invest in biotechnology, medical, new drug research and development, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology sectors.
Business Details
Website
www.diamondbiofund.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 34F, Number 66, Sector 1
- Zhongxiao West Road
- Taipei
- Taiwan
Diamond Biofund Investments (25)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ImmunAdd | 01-Jul-2026 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Rejuvenate Bio | 18-Jun-2026 | Drug Discovery | Generating Revenue | |||
| Syncell | 13-Sep-2023 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Bilayer Therapeutics | 13-Sep-2022 | Drug Discovery | Out of Business | |||
| Genomics BioSci & Tech Company | 01-Nov-2021 | Laboratory Services (Healthcare) | Generating Revenue | |||
| EyeYon Medical | 15-Mar-2021 | Therapeutic Devices | Generating Revenue | |||
| Vita Genomics | 01-Mar-2021 | Drug Discovery | Generating Revenue | |||
| Enimmune Biotech | 01-Jan-2020 | Drug Discovery | Generating Revenue | |||
| Tetanti AgriBiotech | 01-Sep-2018 | Seed Round | Environmental Services (B2B) | Generating Revenue | ||
| EyeYon Medical | 21-Mar-2017 | Later Stage VC | Therapeutic Devices | Generating Revenue |
Diamond Biofund Exits (14)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Genomics BioSci & Tech Company | 11-May-2026 | IPO | |
| StemCyte | 30-Apr-2026 | ||
| Aprinoia Therapeutics | 01-Apr-2026 | ||
| Ativa Medical | 06-Jan-2026 | ||
| Bilayer Therapeutics | 09-Sep-2025 | ||
| The YueZi Resort | 05-Feb-2024 | ||
| IOPtima | 21-Nov-2017 | ||
| CHO Pharma | 27-Sep-2017 | ||
| Sinew Pharma | 29-Jun-2017 | IPO | |
| Synovel Sciences | 01-Mar-2017 | Merger/Acquisition |
Diamond Biofund Investments by Industry, Year, and Region
Diamond Biofund Co-Investors (11)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Kendall Capital Partners | 2 |
|
|
||
| Connecticut Innovations |
|
|
|||
| Darwin Venture Management |
|
|
|||
| Merck & Co |
|
|
|||
| VCapital |
|
|
Diamond Biofund FAQs
-
What is Diamond Biofund?
Founded in 2013, Diamond Biofund is a venture capital firm based in Taipei, Taiwan.
-
When was Diamond Biofund founded?
Diamond Biofund was founded in 2013.
-
Where is Diamond Biofund headquartered?
Diamond Biofund is headquartered in Taipei, Taiwan.
-
What is Diamond Biofund's total asset value?
Diamond Biofund has around in total assets under management.
-
How many investments has Diamond Biofund made?
Diamond Biofund has made 25 investments.
-
What has Diamond Biofund invested in?
Diamond Biofund has made numerous investments in companies like ImmunAdd, Rejuvenate Bio, and Syncell within the Drug Discovery and Discovery Tools (Healthcare) industries.
-
What has Diamond Biofund invested in recently?
Diamond Biofund's latest investment was on 01-Jul-2026 in ImmunAdd, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process